loading page

Prognosis of chronic immune thrombocytopenia in the setting of COVID-19 infection
  • +5
  • Dina Alayan,
  • Tariq Kewan,
  • Mahmoud Alwakeel,
  • Sura Alqaisi,
  • Tarini Gunaratne,
  • Komal Mushtaq,
  • Hamed Daw,
  • Abdo Haddad
Dina Alayan
Cleveland Clinic
Author Profile
Tariq Kewan
Cleveland Clinic
Author Profile
Mahmoud Alwakeel
Cleveland Clinic
Author Profile
Sura Alqaisi
Cleveland Clinic
Author Profile
Tarini Gunaratne
Cleveland Clinic
Author Profile
Komal Mushtaq
Cleveland Clinic
Author Profile
Hamed Daw
Cleveland Clinic
Author Profile
Abdo Haddad
Cleveland Clinic
Author Profile

Abstract

Background Although several studies discussed new-onset thrombocytopenia in the setting of COVID-19 infection, the course of chronic ITP in patients with COVID-19 and the propensity to relapse remains not well addressed. Methods This a retrospective study that included all adult patients with the diagnosis of chronic ITP who admitted to

Peer review status:IN REVISION

12 Jun 2021Submitted to Clinical Case Reports
16 Jun 2021Assigned to Editor
16 Jun 2021Submission Checks Completed
27 Jun 2021Reviewer(s) Assigned
02 Sep 2021Review(s) Completed, Editorial Evaluation Pending
02 Sep 2021Editorial Decision: Revise Minor